Alpha-1 Antitrypsin Replacement in Patients With COPD. 2019

Adam D Wells, and Anna Woods, and Daniel E Hilleman, and Mark A Malesker

Chronic obstructive pulmonary disease can be attributed to genetic conditions and predispositions, among other factors. Alpha-1 antitrypsin deficiency (AATD) is a significant risk factor for COPD development and progression, and aggressive screening for all patients with COPD or adult-onset asthma is encouraged.

UI MeSH Term Description Entries

Related Publications

Adam D Wells, and Anna Woods, and Daniel E Hilleman, and Mark A Malesker
August 1988, Chest,
Adam D Wells, and Anna Woods, and Daniel E Hilleman, and Mark A Malesker
March 1986, Chest,
Adam D Wells, and Anna Woods, and Daniel E Hilleman, and Mark A Malesker
January 2010, Archivos de bronconeumologia,
Adam D Wells, and Anna Woods, and Daniel E Hilleman, and Mark A Malesker
September 2020, Clinics in chest medicine,
Adam D Wells, and Anna Woods, and Daniel E Hilleman, and Mark A Malesker
November 2015, Archivos de bronconeumologia,
Adam D Wells, and Anna Woods, and Daniel E Hilleman, and Mark A Malesker
December 2017, European respiratory review : an official journal of the European Respiratory Society,
Adam D Wells, and Anna Woods, and Daniel E Hilleman, and Mark A Malesker
February 1989, Journal of internal medicine,
Adam D Wells, and Anna Woods, and Daniel E Hilleman, and Mark A Malesker
March 1998, Archivos de bronconeumologia,
Adam D Wells, and Anna Woods, and Daniel E Hilleman, and Mark A Malesker
January 1986, The Indian journal of chest diseases & allied sciences,
Adam D Wells, and Anna Woods, and Daniel E Hilleman, and Mark A Malesker
April 2016, Chronic obstructive pulmonary diseases (Miami, Fla.),
Copied contents to your clipboard!